Delivery Order SPE2DB24D2013-SPE2DB25FCHKN
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.87 firm fixed-price delivery order is for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,281.68 fixed-price delivery order is for the supply of JATENZO 237 MG CAPSULE 120S, a medical product, with a period of performance through December 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,395.61 Firm Fixed Price Delivery Order contract covers the supply of JATENZO 237 MG CAPSULE 120S, a specialty pharmaceutical product. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a $1,380.73 Firm Fixed Price Delivery Order for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2024. Amerisourcebergen is the prime contractor, and there is no mention of any subcontractors. The award is not associated with a...
This federal contract award, valued at $2,562.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of JATENZO 237 MG CAPSULE 120S, with an ultimate completion date of January 3, 2025. The contract is a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,094.07, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,282.21, is for the delivery of JATENZO 237 MG CAPSULE 120S, a medical product. This contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,033.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, with an ultimate completion date of January 23, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,217.27, is for the supply of JATENZO 158 MG CAPSULE 120S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 13, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This federal contract award is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,951.93, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 30, 2024. The contract has a period of performance through July 31, 2024 and is a Firm Fixed Price Delivery Order. No set-aside was used for this award. Amerisourcebergen Drug Corp holds a significant...